<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03078153</url>
  </required_header>
  <id_info>
    <org_study_id>111642</org_study_id>
    <secondary_id>1P30AI117970</secondary_id>
    <nct_id>NCT03078153</nct_id>
  </id_info>
  <brief_title>Effect of Social Media Support and Financial Incentives on PrEP Adherence</brief_title>
  <official_title>The Effect of Social Media Support and Financial Incentives on Adherence to HIV Pre-exposure Prophylaxis in Young MSM of Color in Washington, DC</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>George Washington University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gilead Sciences</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>George Washington University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if social media support and financial incentives&#xD;
      improve adherence to Truvada as PrEP in African American, Latino and Asian MSM aged 18 to 24&#xD;
      living in the Washington, DC area who are at high risk for HIV acquisition.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Actual">December 15, 2020</completion_date>
  <primary_completion_date type="Actual">December 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence To Truvada</measure>
    <time_frame>6 months</time_frame>
    <description>Level of Truvada drug levels inside red blood cells (performed by dried blood spots)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>New Cases of HIV</measure>
    <time_frame>6 months</time_frame>
    <description>Number of reactive HIV rapid and 4th generation tests</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of STIs</measure>
    <time_frame>6 months</time_frame>
    <description>Positive RPR, oropharyngeal/rectal/penile chlamydia and gonorrhea during study</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">57</enrollment>
  <condition>Pre-Exposure Prophylaxis</condition>
  <arm_group>
    <arm_group_label>Financial Incentive</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Provided financial incentive at 3-month and 6-month follow-up visits</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Social Media Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Provided social media support through a facebook group for 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Financial Incentive</intervention_name>
    <description>Participants will receive a $50 gift card at 3- and 6- month follow-up visits.</description>
    <arm_group_label>Financial Incentive</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Social Media Group</intervention_name>
    <description>Participants will be invited to a study Facebook group which will have links to PrEP information and provide a forum for participants to ask questions and communicate their experience with PrEP</description>
    <arm_group_label>Social Media Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male assigned at birth (regardless of current gender identity)&#xD;
&#xD;
          -  Age 18-24&#xD;
&#xD;
          -  Black/African American, Latino or Asian&#xD;
&#xD;
          -  HIV negative&#xD;
&#xD;
          -  History of unprotected anal sex with a man in the last 6 months&#xD;
&#xD;
          -  Living within the DC metropolitan statistical area and anticipate remaining within the&#xD;
             DC area for the next 6 months&#xD;
&#xD;
          -  Not enrolled in any other HIV prevention trial&#xD;
&#xD;
          -  Interested in taking PrEP&#xD;
&#xD;
          -  Not a current PrEP user and have not taken PrEP in the last 30 days&#xD;
&#xD;
          -  Able to provide informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Female sex at birth&#xD;
&#xD;
          -  Age younger than 18 or older than 24&#xD;
&#xD;
          -  Caucasian&#xD;
&#xD;
          -  HIV positive&#xD;
&#xD;
          -  Actively taking PrEP or having taken PrEP within 30 days of enrollment&#xD;
&#xD;
          -  Chronic hepatitis B infection&#xD;
&#xD;
          -  Known renal insufficiency&#xD;
&#xD;
          -  On probation or parole&#xD;
&#xD;
          -  Any other conditions that the Principal Investigator may consider a contraindication&#xD;
             to enrolling in the study&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>male at birth (regardless of current gender identity)</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>24 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Siegel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The GW Medical Faculty Associates</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The GW Medical Faculty Associates</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>March 7, 2017</study_first_submitted>
  <study_first_submitted_qc>March 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 13, 2017</study_first_posted>
  <last_update_submitted>February 1, 2021</last_update_submitted>
  <last_update_submitted_qc>February 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>George Washington University</investigator_affiliation>
    <investigator_full_name>Marc O. Siegel</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

